Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sudarshan Sukhani, s2analytics.com is upbeat on Fortis Healthcare.
Fortis Healthcare can go up to Rs 150 in the next 18 months, says Rajen Shah, Angel Broking. Last month they raised about Rs 2,500 crore via selling 72 percent stake in Religare Health Trust. These would go towards reduction of debt which will bring down the interest cost substantially in the coming quarters.
The Indian market has been flat this week. The benchmark indices, Nifty and Sensex, are trading in a very narrow range. Moneycontrol brings to you some of the stock recommendations given by experts.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Fortis Healthcare can touch Rs 150 in next six months, says SP Tulsian, sptulsian.com.
Short Fortis Healthcare, says Sudarshan Sukhani of s2analytics.com.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Fortis Healthcare can move to Rs 120- 125 in next 1 year, says SP Tulsian, sptulsian.com.
Sell Fortis Healthcare, says Sudarshan Sukhani, s2analytics.com.
SP Tulsian, sptulsian.com shares his view on Fortis Healthcare and Apollo Hospitals.
SP Tulsian, sptulsian.com is positive on Fortis Health
Shardul Kulkarni of Angel Broking is bullish on Fortis Healthcare and bearish on Indiabulls Real Estate and Exide Industries.
Buy Fortis Health, says Abhishek Agarwal of Fortune Interfinance.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Fortis Healthcare can touch Rs 130, says Shardul Kulkarni of Angel Broking.
Buy Fortis Healthcare with a long term view, says PN Vijay, Portfolio Manager.
Exit Fortis Healthcare, says Santosh Kumar Singh of Fortune Interfinance.
Santosh Kumar Singh of Fortune Interfinance is of the view that one should hold Fortis Healthcare.
Hold Fortis Healthcare, says Vidur Pendharkar of trend4casting.com.
Fortis Healthcare is looking good, says Salil Sharma of Kapoor Sharma and Company.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest
Fortis Healthcare has target of Rs 150, says Aunali Rupani, Director of Arm Research.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Fortis Healthcare has target of Rs 176.50, says Nooresh Mirani, AVP Technical of AMSEC Research.